Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Haematologica|February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.Blood Advances|August 8, 2020
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adultsMikkael A Sekeres, Gordon Guyatt, Gregory Abel, et al.Journal of Geriatric Oncology|June 17, 2023
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemiaP Connor Johnson, Jennifer A Woyach, Angela Ulrich, et al.Blood|March 6, 2002
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyMoshe Talpaz, Richard T Silver, Brian J Druker, et al.Science (New York, N.Y.)|October 29, 2011
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapyTriona Ni Chonghaile, Kristopher A Sarosiek, Thanh-Trang Vo, et al.Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.Blood|August 18, 2021
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinibXin Victoria Wang, Curtis A Hanson, Renee C Tschumper, et al.The New England Journal of Medicine|March 1, 2002
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemiaHagop Kantarjian, Charles Sawyers, Andreas Hochhaus, et al.Pageof 15